FSHD Region Gene 1 (FRG1) (N-Term) Peptid
Kurzübersicht für FSHD Region Gene 1 (FRG1) (N-Term) Peptid (ABIN8101013)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- FRG1 Peptide - N-terminal region
-
Sequenz
- GTKTKSKKKK SKDKKRKREE DEETQLDIVG IWWTVTNFGE ISGTIAIEMD
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-FRG1 Antibody (ARP76171_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- FRG1 (FSHD Region Gene 1 (FRG1))
-
Hintergrund
-
Background Information: This gene maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). It is evolutionarily conserved and has related sequences on multiple human chromosomes but DNA sequence analysis did not reveal any homology to known genes. In vivo studies demonstrate the encoded protein is localized to the nucleolus.
Alternative Symbols: FRG1,
-
Molekulargewicht
- 28kDa
-
Gen-ID
- 2483
-
NCBI Accession
- NP_004468
-
UniProt
- Q14331
Target
-
